We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$125B
AUM Growth
+$2.58B
Cap. Flow
-$3.77B
Cap. Flow %
-3.02%
Top 10 Hldgs %
25.94%
Holding
7,845
New
463
Increased
3,647
Reduced
2,883
Closed
246

Sector Composition

Rank Sector Weight
1 Financials 4.66%
2 Technology 4.22%
3 Healthcare 2.96%
4 Consumer Discretionary 2.91%
5 Industrials 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVEO
7051
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$7K ﹤0.01%
268
+1
+0.4% +$31
AVEO
7052
PUT
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$7K ﹤0.01%
+250
New +$7.76K
NVLN
7053
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$7K ﹤0.01%
2,237
+2,234
+74,467% +$10.7K
PETX
7054
DELISTED
Aratana Therapeutics, Inc.
PETX
$7K ﹤0.01%
1,253
-1,050
-46% -$6.42K
LGCY
7055
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$7K ﹤0.01%
4,320
+2,320
+116% +$3.46K
KERX
7056
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$7K ﹤0.01%
1,525
-39,207
-96% -$216K
RAS
7057
DELISTED
RAIT Financial Trust
RAS
$7K ﹤0.01%
18,656
+18,311
+5,308% +$8.27K
ORBC
7058
DELISTED
ORBCOMM, Inc.
ORBC
$7K ﹤0.01%
671
+453
+208% +$4.79K
AVK
7059
Advent Convertible and Income Fund
AVK
$540M
$6K ﹤0.01%
402
+25
+7% +$389
BLW icon
7060
BlackRock Limited Duration Income Trust
BLW
$491M
$6K ﹤0.01%
400
CELC icon
7061
Celcuity
CELC
$4.02B
$6K ﹤0.01%
+317
New +$5.58K
CGO
7062
Calamos Global Total Return Fund
CGO
$122M
$6K ﹤0.01%
394
CIGI icon
7063
Colliers International
CIGI
$5.31B
$6K ﹤0.01%
97
+3
+3% +$173
CLNE icon
7064
CALL
Clean Energy Fuels
CLNE
$421M
$6K ﹤0.01%
3,000
-1,200
-29% -$2.65K
DSGX icon
7065
Descartes Systems
DSGX
$6.48B
$6K ﹤0.01%
206
+4
+2% +$115
FSV icon
7066
FirstService
FSV
$6.58B
$6K ﹤0.01%
89
+1
+1% +$69
GHYG icon
7067
iShares US & Intl High Yield Corp Bond ETF
GHYG
$193M
$6K ﹤0.01%
+118
New +$6.01K
GKOS icon
7068
Glaukos
GKOS
$8.89B
$6K ﹤0.01%
244
-1,668
-87% -$49.6K
GLU
7069
Gabelli Utility & Income Trust
GLU
$115M
$6K ﹤0.01%
+300
New +$6.13K
EUHY
7070
iShares Euro High Yield Corporate Bond USD Hedged ETF
EUHY
$240M
$6K ﹤0.01%
+113
New +$6.05K
ISRA icon
7071
VanEck Israel ETF
ISRA
$151M
$6K ﹤0.01%
200
KNX icon
7072
CALL
Knight Transportation
KNX
$11.4B
$6K ﹤0.01%
144
-72
-33% -$2.96K
KRMA
7073
DELISTED
Global X Conscious Companies ETF
KRMA
$6K ﹤0.01%
294
LSAK icon
7074
Lesaka Technologies
LSAK
$392M
$6K ﹤0.01%
453
-1
-0.2% -$10
METC icon
7075
Ramaco Resources Class A
METC
$637M
$6K ﹤0.01%
+942
New +$5.07K

Similar funds

Citigroup's Q4 2017 Portfolio in Review

As of Q4 2017, Citigroup held 7,845 positions worth $125B, up 2.1% from $122B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Citigroup withdrew a net $3.77B in Q4 2017, closing 246 positions and reducing 2,883 holdings. Its most notable exit was CR Bard Inc., an estimated $210M position sold in full.

By sector, the portfolio is most concentrated in Financials at 4.7% of assets, up from 4.4% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Citigroup opened a new position in Global X US Preferred ETF worth $19.9M.

  • Citigroup's largest Q4 2017 buy was Global X US Preferred ETF: 800,000 shares worth $19.9M.
  • Citigroup added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2017, an estimated $341M increase.
  • Citigroup's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.83B.
  • Citigroup fully exited CR Bard Inc. in Q4 2017, selling an estimated $210M.
  • Citigroup's ten largest holdings make up 26% of its $125B portfolio in Q4 2017.
  • Citigroup opened 463 new positions and closed 246 in Q4 2017.
  • Citigroup's portfolio value rose 2.1% quarter-over-quarter to $125B.

Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.